RealNews

HHS to Acquire New Anthrax Therapeutic Treatment for Stockpile

The Department of Health and Human Services (HHS) announced today it will purchase 20,000 treatment courses of ABthrax, an anthrax therapeutic treatment, from Human Genome Sciences of Rockville, Md. for $165,205,217. Delivery is expected to begin in 2009. Under the terms of the agreement, full payment to Human Genome Sciences is contingent on the product receiving licensure from the Food and Drug Administration. Full Story

OODA Analyst

OODA Analyst

OODA is comprised of a unique team of international experts capable of providing advanced intelligence and analysis, strategy and planning support, risk and threat management, training, decision support, crisis response, and security services to global corporations and governments.